A new in vitro study shows that a 2% concentration of TiAB—a compound based on silver-bound titanium dioxide—is sufficient to exert strong bactericidal activity within 24 hours against Gram-negative bacteria and support wound healing.

This is the first international pharmacovigilance study specifically focused on a fixed-dose eye drop that combines an antibiotic and an anti-inflammatory steroid, indicated for the prevention and treatment of inflammation and the prevention of infection following cataract surgery in adults.

100 young ophthalmologists and 40 experts to discuss professional development in ophthalmology, with a focus on clinical research, emerging subspecialties, career paths in the public and private sectors, and artificial intelligence.

By combining eye health innovation with real environmental impact, NTC is committed to removing an equivalent weight of ocean plastic for every bottle sold. To date, 10,300 bottles have been recovered, symbolizing NTC's pledge to collect 103 kg of marine litter.